1. Home
  2. BLNK vs CCCC Comparison

BLNK vs CCCC Comparison

Compare BLNK & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLNK
  • CCCC
  • Stock Information
  • Founded
  • BLNK 2009
  • CCCC 2015
  • Country
  • BLNK United States
  • CCCC United States
  • Employees
  • BLNK N/A
  • CCCC N/A
  • Industry
  • BLNK Industrial Specialties
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLNK Consumer Discretionary
  • CCCC Health Care
  • Exchange
  • BLNK Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • BLNK 77.3M
  • CCCC 104.4M
  • IPO Year
  • BLNK N/A
  • CCCC 2020
  • Fundamental
  • Price
  • BLNK $0.95
  • CCCC $2.35
  • Analyst Decision
  • BLNK Buy
  • CCCC Buy
  • Analyst Count
  • BLNK 8
  • CCCC 3
  • Target Price
  • BLNK $2.61
  • CCCC $12.00
  • AVG Volume (30 Days)
  • BLNK 4.3M
  • CCCC 1.6M
  • Earning Date
  • BLNK 08-06-2025
  • CCCC 07-31-2025
  • Dividend Yield
  • BLNK N/A
  • CCCC N/A
  • EPS Growth
  • BLNK N/A
  • CCCC N/A
  • EPS
  • BLNK N/A
  • CCCC N/A
  • Revenue
  • BLNK $109,383,000.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • BLNK N/A
  • CCCC N/A
  • Revenue Next Year
  • BLNK $31.15
  • CCCC N/A
  • P/E Ratio
  • BLNK N/A
  • CCCC N/A
  • Revenue Growth
  • BLNK N/A
  • CCCC 98.56
  • 52 Week Low
  • BLNK $0.63
  • CCCC $1.09
  • 52 Week High
  • BLNK $3.75
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • BLNK 55.76
  • CCCC 63.62
  • Support Level
  • BLNK $0.96
  • CCCC $1.36
  • Resistance Level
  • BLNK $1.10
  • CCCC $2.17
  • Average True Range (ATR)
  • BLNK 0.08
  • CCCC 0.15
  • MACD
  • BLNK 0.00
  • CCCC 0.05
  • Stochastic Oscillator
  • BLNK 52.94
  • CCCC 67.11

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: